How Do GLP-1 Receptor Agonists, Like Ozempic or Mounjaro, Work?
网页2024年6月14日 · GLP-1 receptor agonists also bind to the GLP-1 receptors on certain neurons in the brain to decrease hunger and increase satiety. They have been shown to slow gastric emptying within the first hour of eating, resulting in the feeling of being full. Patients who use GLP-1 receptor agonists experience reduced appetite and …
The 2024 Update to the American Diabetes Association Standards …
网页2024年1月12日 · The American Diabetes Association (ADA) has updated its guidelines for the “Standards of Care” for patients with diabetes. The report has been published in Diabetes Care.. In the 2024 update, the ADA focused on patient-centered care, person-first language, and updated screening and treatment approaches based on …
Type 2 Diabetes Medications That Induce Weight Loss
网页2024年3月22日 · A weight loss of 5% to 15% can improve obesity-related complications. 1,2. There are approved medications to help treat obesity, including phentermine (Lomaira®), orlistat (Alli®), topiramate (Trokendi XR®), and naltrexone/bupropion (Contrave®). However, these are not indicated to treat type 2 diabetes. 3.
Improvements in Insulin Resistance With Semaglutide Primarily a …
网页2019年4月16日 · Treatment with semaglutide, a once-weekly glucagon-like peptide-1 (GLP-1) analog, consistently reduced body weight and insulin resistance in patients with type 2 diabetes, with improvements in insulin resistance being positively associated with weight loss, according to study results published in The Journal of …
The Growing Problem of Peripheral Neuropathy in Prediabetes
网页2015年7月2日 · The researchers found that the prevalence of peripheral neuropathy was 29% in adults with normal glycemia, as compared with 49% in adults with prediabetes and 50% in adults with new-onset diabetes. For the study, the researchers defined peripheral neuropathy using the Michigan Neuropathy Screening Instrument (MNSI) scores (>2).
Secondary Hypogonadism: Causes and Potential Treatment
网页January 15, 2016. Most cases of secondary hypogonadism appear to respond to selective estrogen receptor modulator (SERM) therapy. However, intolerance to SERMs is common or they may cause unwanted side effects, according to Paul Turek, MD, director of the Turek Clinic in Beverly Hills and San Francisco, California.
Rethinking the Role of Constipation in Diabetes
网页April 23, 2021. Physicians may want to rethink the role of chronic constipation in diabetes management, say experts calling for more research in this area. Constipation has long been thought of as a benign condition and one better suited for self-management. It affects approximately 60% of patients with diabetes, up to 34% of the elderly in the ...
COVID-19 Vaccine Linked to Exacerbation of Graves Disease
网页April 11, 2022. Clinicians should be aware of the potential development or exacerbation of autoimmune thyroid disorders in predisposed individuals after exposure to the COVID-19 vaccination, researchers reported in the Journal of Clinical Endocrinology and Metabolism. The investigators presented their findings from a case series of 12 patients ...
Hyperthyroidism and Thyrotoxicosis: Diagnosis and Management
网页2020年2月19日 · Hyperthyroidism refers to increased thyroid hormone synthesis and secretion from the thyroid gland, whereas thyrotoxicosis is characterized by the clinical manifestations of inappropriately high thyroid hormone action in tissues. 1 These manifestations result from hormone excess at any level of …
Gestational Diabetes Screening Guidelines Updated by the ACOG
网页2024年7月26日 · Gestational Diabetes Screening. The ACOG recommends the 2-step approach for glucose screening with a 50-gram non-fasting screening followed by a 100-gram 3-hour diagnostic test within 24 to 28 weeks of gestation. Alternatively, providers may recommend the 1-step 75-gram oral glucose tolerance test (OGTT) on …